• Esperion Therapeutics' (ESPR) Market Outperform Rating Reaffirmed at JMP Securities

    Source: Buzz FX / 11 Feb 2025 11:16:12   America/New_York


    Esperion Therapeutics' (ESPR) Market Outperform Rating Reaffirmed at JMP Securities Written by MarketBeat February 11, 2025 Share Link copied to clipboard. Esperion Therapeutics ( NASDAQ:ESPR - Get Free Report ) 's stock had its "market out
    Read more...
Share on,